Cite

HARVARD Citation

    Fujisawa, S. et al. (n.d.). Phase II study of imatinib‐based chemotherapy for newly diagnosed BCR‐ABL‐positive acute lymphoblastic leukemia. American journal of hematology. 92 (4), pp. 367-374. [Online]. 
  
Back to record